20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Calithera Biosciences’s Stock Price And Volume Action
Calithera Biosciences’s (NASDAQ:CALA) stock has been falling Monday, down 41.55% to a price of $2.92. The stock’s volume is currently 9.18 million, which is roughly 1058.14% of its recent 30-day volume average of 867.52 thousand.
Why It’s Moving
Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: Calithera Biosciences shares are trading lower after the company announced that its CANTATA study of Telaglenastat in Renal Cell Carcinoma did not achieve its primary endpoint. The company also announced a reduction in workforce by roughly 35%.
Insights On Recent Price Action
The 50-day moving average price of Calithera Biosciences’s stock was $4.54 when this article was published. The stock reached a high of $8.18 and a low of $2.99 in the past 52 weeks.
If you’re looking for timely and concise explanations of why a stock is moving, check out Benzinga Pro. Subscribers get ‘Why Is It Moving’ alerts as soon as our research team identifies the cause of the price action in a stock. Click here to learn more.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!